{
    "organizations": [],
    "uuid": "0dbc1b8a13eaeae33e2897faf930d59828e5d7ec",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenzhen-hepalink-pharmaceutical-a/brief-shenzhen-hepalink-pharmaceutical-announces-change-in-accounting-policy-idUSL3N1S21T8",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenzhen Hepalink Pharmaceutical announces change in accounting policy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25(Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd\n* Says it changes accounting policy based on accounting standards for business enterprises No. 16â€”government subsidies, which was disclosed by the Ministry of Finance on May 10, 2017, effective June 12, 2017\nSource text in Chinese: goo.gl/fMUh5Z\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-25T11:28:00.000+03:00",
    "crawled": "2018-04-25T14:55:24.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "shenzhen",
        "hepalink",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "change",
        "accounting",
        "policy",
        "based",
        "accounting",
        "standard",
        "business",
        "enterprise",
        "subsidy",
        "disclosed",
        "ministry",
        "finance",
        "may",
        "effective",
        "june",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}